Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Recruiting × Waldenstrom Macroglobulinemia × Clear all

Phase

Phase 2 12 Phase 1 9 Phase NA 4 Phase 1/2 3 Phase 4 1 Phase 3 1 Phase 2/3 1

Status

Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 18 Carcinoma, Non-Small-Cell Lung 12 Breast Neoplasms 10 Prostatic Neoplasms 9 Pancreatic Neoplasms 9 Leukemia, Myeloid, Acute 9 Colorectal Neoplasms 9 Squamous Cell Carcinoma of Head and Neck 8 Precursor Cell Lymphoblastic Leukemia-Lymphoma 7 Neoplasm Metastasis 7 Myasthenia Gravis 7 Endometrial Neoplasms 7 Stomach Neoplasms 6 Lung Neoplasms 6 Hematologic Neoplasms 6 Carcinoma, Hepatocellular 6 Urinary Bladder Neoplasms 5 Recurrence 5 Ovarian Neoplasms 5 Leukemia 5 Neoplasms, Plasma Cell 4 Multiple Myeloma 4 Melanoma 4 Lymphoma 4 Infections 4 Head and Neck Neoplasms 4 Fatigue 4 Biliary Tract Neoplasms 4 Uterine Cervical Neoplasms 3 Rectal Neoplasms 3

Interventions

ibrutinib 1 Rituximab 1 Dexamethasone 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04061512 2024-05-10

RAINBOW

University College, London

Phase 2/3 Recruiting

Waldenstrom Macroglobulinemia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡